Cargando…

Lost in translation? A multilingual Query Builder improves the quality of PubMed queries: a randomised controlled trial

BACKGROUND: MEDLINE is the most widely used medical bibliographic database in the world. Most of its citations are in English and this can be an obstacle for some researchers to access the information the database contains. We created a multilingual query builder to facilitate access to the PubMed s...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuers, Matthieu, Joulakian, Mher, Kerdelhué, Gaetan, Segas, Léa, Grosjean, Julien, Darmoni, Stéfan J., Griffon, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496216/
https://www.ncbi.nlm.nih.gov/pubmed/28673304
http://dx.doi.org/10.1186/s12911-017-0490-9
_version_ 1783247928109826048
author Schuers, Matthieu
Joulakian, Mher
Kerdelhué, Gaetan
Segas, Léa
Grosjean, Julien
Darmoni, Stéfan J.
Griffon, Nicolas
author_facet Schuers, Matthieu
Joulakian, Mher
Kerdelhué, Gaetan
Segas, Léa
Grosjean, Julien
Darmoni, Stéfan J.
Griffon, Nicolas
author_sort Schuers, Matthieu
collection PubMed
description BACKGROUND: MEDLINE is the most widely used medical bibliographic database in the world. Most of its citations are in English and this can be an obstacle for some researchers to access the information the database contains. We created a multilingual query builder to facilitate access to the PubMed subset using a language other than English. The aim of our study was to assess the impact of this multilingual query builder on the quality of PubMed queries for non-native English speaking physicians and medical researchers. METHODS: A randomised controlled study was conducted among French speaking general practice residents. We designed a multi-lingual query builder to facilitate information retrieval, based on available MeSH translations and providing users with both an interface and a controlled vocabulary in their own language. Participating residents were randomly allocated either the French or the English version of the query builder. They were asked to translate 12 short medical questions into MeSH queries. The main outcome was the quality of the query. Two librarians blind to the arm independently evaluated each query, using a modified published classification that differentiated eight types of errors. RESULTS: Twenty residents used the French version of the query builder and 22 used the English version. 492 queries were analysed. There were significantly more perfect queries in the French group vs. the English group (respectively 37.9% vs. 17.9%; p < 0.01). It took significantly more time for the members of the English group than the members of the French group to build each query, respectively 194 sec vs. 128 sec; p < 0.01. CONCLUSIONS: This multi-lingual query builder is an effective tool to improve the quality of PubMed queries in particular for researchers whose first language is not English.
format Online
Article
Text
id pubmed-5496216
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54962162017-07-05 Lost in translation? A multilingual Query Builder improves the quality of PubMed queries: a randomised controlled trial Schuers, Matthieu Joulakian, Mher Kerdelhué, Gaetan Segas, Léa Grosjean, Julien Darmoni, Stéfan J. Griffon, Nicolas BMC Med Inform Decis Mak Research Article BACKGROUND: MEDLINE is the most widely used medical bibliographic database in the world. Most of its citations are in English and this can be an obstacle for some researchers to access the information the database contains. We created a multilingual query builder to facilitate access to the PubMed subset using a language other than English. The aim of our study was to assess the impact of this multilingual query builder on the quality of PubMed queries for non-native English speaking physicians and medical researchers. METHODS: A randomised controlled study was conducted among French speaking general practice residents. We designed a multi-lingual query builder to facilitate information retrieval, based on available MeSH translations and providing users with both an interface and a controlled vocabulary in their own language. Participating residents were randomly allocated either the French or the English version of the query builder. They were asked to translate 12 short medical questions into MeSH queries. The main outcome was the quality of the query. Two librarians blind to the arm independently evaluated each query, using a modified published classification that differentiated eight types of errors. RESULTS: Twenty residents used the French version of the query builder and 22 used the English version. 492 queries were analysed. There were significantly more perfect queries in the French group vs. the English group (respectively 37.9% vs. 17.9%; p < 0.01). It took significantly more time for the members of the English group than the members of the French group to build each query, respectively 194 sec vs. 128 sec; p < 0.01. CONCLUSIONS: This multi-lingual query builder is an effective tool to improve the quality of PubMed queries in particular for researchers whose first language is not English. BioMed Central 2017-07-03 /pmc/articles/PMC5496216/ /pubmed/28673304 http://dx.doi.org/10.1186/s12911-017-0490-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Schuers, Matthieu
Joulakian, Mher
Kerdelhué, Gaetan
Segas, Léa
Grosjean, Julien
Darmoni, Stéfan J.
Griffon, Nicolas
Lost in translation? A multilingual Query Builder improves the quality of PubMed queries: a randomised controlled trial
title Lost in translation? A multilingual Query Builder improves the quality of PubMed queries: a randomised controlled trial
title_full Lost in translation? A multilingual Query Builder improves the quality of PubMed queries: a randomised controlled trial
title_fullStr Lost in translation? A multilingual Query Builder improves the quality of PubMed queries: a randomised controlled trial
title_full_unstemmed Lost in translation? A multilingual Query Builder improves the quality of PubMed queries: a randomised controlled trial
title_short Lost in translation? A multilingual Query Builder improves the quality of PubMed queries: a randomised controlled trial
title_sort lost in translation? a multilingual query builder improves the quality of pubmed queries: a randomised controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496216/
https://www.ncbi.nlm.nih.gov/pubmed/28673304
http://dx.doi.org/10.1186/s12911-017-0490-9
work_keys_str_mv AT schuersmatthieu lostintranslationamultilingualquerybuilderimprovesthequalityofpubmedqueriesarandomisedcontrolledtrial
AT joulakianmher lostintranslationamultilingualquerybuilderimprovesthequalityofpubmedqueriesarandomisedcontrolledtrial
AT kerdelhuegaetan lostintranslationamultilingualquerybuilderimprovesthequalityofpubmedqueriesarandomisedcontrolledtrial
AT segaslea lostintranslationamultilingualquerybuilderimprovesthequalityofpubmedqueriesarandomisedcontrolledtrial
AT grosjeanjulien lostintranslationamultilingualquerybuilderimprovesthequalityofpubmedqueriesarandomisedcontrolledtrial
AT darmonistefanj lostintranslationamultilingualquerybuilderimprovesthequalityofpubmedqueriesarandomisedcontrolledtrial
AT griffonnicolas lostintranslationamultilingualquerybuilderimprovesthequalityofpubmedqueriesarandomisedcontrolledtrial